JP2000505469A5 - - Google Patents

Download PDF

Info

Publication number
JP2000505469A5
JP2000505469A5 JP1997530671A JP53067197A JP2000505469A5 JP 2000505469 A5 JP2000505469 A5 JP 2000505469A5 JP 1997530671 A JP1997530671 A JP 1997530671A JP 53067197 A JP53067197 A JP 53067197A JP 2000505469 A5 JP2000505469 A5 JP 2000505469A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997530671A
Other languages
English (en)
Japanese (ja)
Other versions
JP4102440B2 (ja
JP2000505469A (ja
Filing date
Publication date
Priority claimed from FR9602472A external-priority patent/FR2745290B1/fr
Application filed filed Critical
Publication of JP2000505469A publication Critical patent/JP2000505469A/ja
Publication of JP2000505469A5 publication Critical patent/JP2000505469A5/ja
Application granted granted Critical
Publication of JP4102440B2 publication Critical patent/JP4102440B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP53067197A 1996-02-28 1997-02-27 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用 Expired - Lifetime JP4102440B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/02472 1996-02-28
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/000351 WO1997031929A1 (fr) 1996-02-28 1997-02-27 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
JP2000505469A JP2000505469A (ja) 2000-05-09
JP2000505469A5 true JP2000505469A5 (OSRAM) 2004-11-25
JP4102440B2 JP4102440B2 (ja) 2008-06-18

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53067197A Expired - Lifetime JP4102440B2 (ja) 1996-02-28 1997-02-27 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用

Country Status (31)

Country Link
US (1) US6096714A (OSRAM)
EP (1) EP0885234B1 (OSRAM)
JP (1) JP4102440B2 (OSRAM)
KR (1) KR100486053B1 (OSRAM)
CN (1) CN1168734C (OSRAM)
AP (1) AP952A (OSRAM)
AR (1) AR005999A1 (OSRAM)
AT (1) ATE217633T1 (OSRAM)
AU (1) AU716204B2 (OSRAM)
BG (1) BG63207B1 (OSRAM)
BR (1) BR9707709B1 (OSRAM)
CZ (1) CZ293893B6 (OSRAM)
DE (1) DE69712610T2 (OSRAM)
DK (1) DK0885234T3 (OSRAM)
EA (1) EA001376B1 (OSRAM)
EE (1) EE9800265A (OSRAM)
ES (1) ES2176698T3 (OSRAM)
FR (1) FR2745290B1 (OSRAM)
HU (1) HU227567B1 (OSRAM)
IL (1) IL125622A (OSRAM)
NO (1) NO983955L (OSRAM)
NZ (1) NZ331600A (OSRAM)
OA (1) OA10845A (OSRAM)
PL (1) PL191736B1 (OSRAM)
PT (1) PT885234E (OSRAM)
SK (1) SK118498A3 (OSRAM)
TR (1) TR199801713T2 (OSRAM)
UA (1) UA58504C2 (OSRAM)
WO (1) WO1997031929A1 (OSRAM)
YU (1) YU37098A (OSRAM)
ZA (1) ZA971659B (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021870A1 (en) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
AU9649598A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
IL144178A0 (en) 1999-01-27 2002-05-23 Pfizer Prod Inc Ketolide antibiotics
OA11945A (en) * 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6183800A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010878A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
CA2703475A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
EP2358379B1 (en) * 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
KR101945324B1 (ko) 2010-05-20 2019-02-07 셈프라 파마슈티컬스, 인크. 매크로라이드들 및 케톨라이드들과 이의 중간체들을 제조하는 공정들
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Similar Documents

Publication Publication Date Title
JP2000512519A5 (OSRAM)
JP2000502280A5 (OSRAM)
JP2000501771A5 (OSRAM)
JP2002505019A5 (OSRAM)
JP2000501599A5 (OSRAM)
JP2001525822A5 (OSRAM)
JP2000501018A5 (OSRAM)
JP2000504881A5 (OSRAM)
JP2000501324A5 (OSRAM)
JP2002512644A5 (OSRAM)
JP2000501338A5 (OSRAM)
JP2000501825A5 (OSRAM)
JP2001500472A5 (OSRAM)
JP2001506986A5 (OSRAM)
JP2001508367A5 (OSRAM)
JP2000502425A5 (OSRAM)
JP2000515107A5 (OSRAM)
JP2000502568A5 (OSRAM)
JP2000501774A5 (OSRAM)
JP2000502570A5 (OSRAM)
JP2001506920A5 (OSRAM)
JP2000501876A5 (OSRAM)
JP2001506378A5 (OSRAM)
JP2001503400A5 (OSRAM)
JP2000501744A5 (OSRAM)